Načítá se...
BFAR coordinates TGFβ signaling to modulate Th9-mediated cancer immunotherapy
TGFβ is essential for the generation of anti-tumor Th9 cells; on the other hand, it causes resistance against anti-tumor immunity. Despite recent progress, the underlying mechanism reconciling the double-edged effect of TGFβ signaling in Th9-mediated cancer immunotherapy remains elusive. Here, we fi...
Uloženo v:
| Vydáno v: | J Exp Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Rockefeller University Press
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8091105/ https://ncbi.nlm.nih.gov/pubmed/33914044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20202144 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|